PanCAN Urges Bigger Pancreatic Cancer Research Push
Pancreatic Cancer Action Network CEO Julie Fleshman called for greater research investment on World Pancreatic Cancer Day, November 22.
Updated on Nov. 22, 2026 in Cancer

Live Poll
Should the federal government increase funding for cancer research?
Julie Fleshman, President and CEO of Pancreatic Cancer Action Network, called for greater investment in pancreatic cancer research on World Pancreatic Cancer Day. Landmarks across the United States were illuminated purple to mark the observance.
Why it matters
Pancreatic cancer advocates are pressing Congress and the public to direct more resources toward research and early detection. The nationwide illuminations and community events aim to raise awareness of a disease advocates say needs greater attention.
The observance was marked through coordinated events, with no specific research funding figures or patient statistics reported in the source. Details of any funding request or policy outcome remain unspecified.
The players
Pancreatic Cancer Action Network (PanCAN)
A patient advocacy organization focused on pancreatic cancer research funding, patient services, and public policy advocacy in the United States.
Julie Fleshman
President and CEO of Pancreatic Cancer Action Network, a longtime advocate for increased pancreatic cancer research funding.
Terri Sewell
U.S. Representative from Alabama who hosted a World Pancreatic Cancer Day roundtable with members of Congress.
The details
Fleshman joined Representative Terri Sewell for a World Pancreatic Cancer Day roundtable with members of Congress in Washington, D.C., where discussion covered advancements in early detection and treatment. Separately, Fleshman hosted an evening event in Northern California, and PanCAN volunteers organized community events nationwide.
Timeline
November 21, 2026: Fleshman and Brian Wolpin joined Rep. Sewell's pancreatic cancer meeting.
November 22, 2026: World Pancreatic Cancer Day, marked by nationwide purple illuminations.
Health Landscape
The observance continues a multi-year push by Pancreatic Cancer Action Network for greater federal research investment in a disease with historically limited treatment options. The congressional roundtable places that advocacy within ongoing discussions over federal biomedical research priorities.
Pancreatic cancer patients and families may see changes in research priorities and early detection approaches if federal funding increases. Readers concerned about risk factors should discuss screening options with a physician.
The takeaway
Advocacy efforts like World Pancreatic Cancer Day aim to keep the disease in front of lawmakers and the public. Readers can follow ongoing research funding debates through official congressional and health agency updates.
Further reading
Explore more cancer coverage for context on research and treatment developments.
Source note: This article includes information reported by Oncodaily - Oncology News, Insights, Stories.
Live Poll
Should the federal government increase funding for cancer research?





